Gene expression profile related to the progression of preneoplastic nodules toward hepatocellular carcinoma in rats

被引:32
作者
Perez-Carreon, Julio Isael
Lopez-Garcia, Cristina
Fattel-Fazenda, Samia
Arce-Popoca, Evelia
Aleman-Lazarini, Leticia
Hernandez-Garcia, Sergio
Le Berre, Veronique
Sokol, Serguei
Francois, Jean Marie
Villa-Trevino, Saul
机构
[1] CINVESTAV, Dept Biol Celular, Mexico City 07360, DF, Mexico
[2] Inst Natl Sci Appl, Ctr Bioingenierie Gilbert Durand, Transcriptome Biochips Platform Genopole Toulouse, UMR CNRS 5504,UMR INRA 792, F-31077 Toulouse 4, France
来源
NEOPLASIA | 2006年 / 8卷 / 05期
关键词
hepatocarcinogenesis; transcriptomic; redox control; cancer markers; glutathione metabolism;
D O I
10.1593/neo.05841
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, we investigated the time course gene expression profile of preneoplastic nodules and hepatocellular carcinomas (HCC) to define the genes implicated in cancer progression in a resistant hepatocyte model. Tissues that included early nodules (1 month, ENT-1), persistent nodules (5 months, ENT-5), dissected HCC (12 months), and normal livers (NL) from adult rats were analyzed by cDNA arrays including 1185 rat genes. Differential genes were derived in each type of sample (n = 3) by statistical analysis. The relationship between samples was described in a Venn diagram for 290 genes. From these, 72 genes were shared between tissues with nodules and HCC. In addition, 35 genes with statistical significance only in HCC and with extreme ratios were identified. Differential expression of 11 genes was confirmed by comparative reverse transcription-polymerase chain reaction, whereas that of 2 genes was confirmed by immunohistochemistry. Members involved in cytochrome P450 and second-phase metabolism were downregulated, whereas genes involved in glutathione metabolism were upregulated, implicating a possible role of glutathione and oxidative regulation. We provide a gene expression profile related to the progression of nodules into HCC, which contributes to the understanding of liver cancer development and offers the prospect for chemoprevention strategies or early treatment of HCC.
引用
收藏
页码:373 / U18
页数:18
相关论文
共 53 条
[1]  
Belinsky MG, 2002, CANCER RES, V62, P6172
[2]   Comparative PCR: An improved method to detect gene amplification [J].
Brass, N ;
Heckel, D ;
Meese, E .
BIOTECHNIQUES, 1998, 24 (01) :22-+
[3]   Chemoprotective effect of caffeic acid phenethyl ester on promotion in a medium-term rat hepatocarcinogenesis assay [J].
Carrasco-Legleu, CE ;
Márquez-Rosado, L ;
Fattel-Fazenda, S ;
Arce-Popoca, E ;
Pérez-Carreón, JI ;
Villa-Treviño, S .
INTERNATIONAL JOURNAL OF CANCER, 2004, 108 (04) :488-492
[4]   DECREASED ACTIVITY OF LIVER GLUTATHIONE-PEROXIDASE IN HUMAN HEPATOCELLULAR-CARCINOMA [J].
CASARIL, M ;
GABRIELLI, GB ;
DUSI, S ;
NICOLI, N ;
BELLISOLA, G ;
CORROCHER, R .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (08) :941-944
[5]  
CHERIAN MG, 1994, TOXICOL APPL PHARM, V126, P1, DOI 10.1006/taap.1994.1083
[6]  
Choi Byung Ihn, 2004, Liver Transpl, V10, pS20, DOI 10.1002/lt.20038
[7]   Expression profiling in multistage hepatocarcinogenesis: Identification of HSP70 as a molecular marker of early hepatocellular carcinoma [J].
Chuma, M ;
Sakamoto, M ;
Yamazaki, K ;
Ohta, T ;
Ohki, M ;
Asaka, M ;
Hirohashi, S .
HEPATOLOGY, 2003, 37 (01) :198-207
[8]   GENOMIC SEQUENCING [J].
CHURCH, GM ;
GILBERT, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (07) :1991-1995
[9]   REDUCTION OF LIVER GLUTATHIONE-PEROXIDASE ACTIVITY AND DEFICIENCY OF SERUM SELENIUM IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA [J].
CORROCHER, R ;
CASARIL, M ;
BELLISOLA, G ;
GABRIELLI, G ;
HULPE, M ;
GAROFOLI, E ;
NICOLI, N .
TUMORI, 1986, 72 (06) :617-619
[10]   EFFECTS OF OXIDATIVE STRESS-INDUCED BY REDOX-ENZYME MODULATION ON THE PROGRESSION STAGE OF RAT HEPATOCARCINOGENESIS [J].
DENDA, A ;
TANG, Q ;
TSUJIUCHI, T ;
TSUTSUMI, M ;
AMANUMA, T ;
MURATA, Y ;
TAMURA, K ;
HORIGUCHI, K ;
NAKAE, D ;
KONISHI, Y .
CARCINOGENESIS, 1993, 14 (01) :95-101